References
Rock GA. Management of thrombotic thrombocytopenic purpura. Br J Haematol. 2000;109:496–507. doi:10.1046/j.1365-2141.2000.01941.x.
Torok TJ, Holman RC, Chorba TL. Increasing mortality from thrombotic thrombocytopenic purpura in the United States-analysis of national mortality data, 1968–1991. Am J Hematol. 1995;l50:84–90.
Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood. 2002;100:2292–302. doi:10.1182/blood-2002-04-1199.
Furlan M, Robles R, Solenthaler M, Wassmer M, Sandoz P, Lämmle B. Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura. Blood. 1997;89:3097–103.
Tsai HM, Lian EC. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med. 1998;339:1585–94. doi:10.1056/NEJM199811263392203.
Levy GG, Nichols WC, Lian EC, et al. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature. 2001;413:488–94. doi:10.1038/35097008.
Rock GA, Shumak KH, Buskard NA, et al. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. N Engl J Med. 1991;325:393–7.
Fontana S, Kremer Hovinga JA, Lämmle B, Mansouri Taleghani B. Treatment of thrombotic thrombocytopenic purpura. Vox Sang. 2006;90:245–54. doi:10.1111/j.1423-0410.2006.00747.x.
Shumak KH, Rock GA, Nair RC. Late relapses in patients successfully treated for thrombotic thrombocytopenic purpura. Canadian Apheresis Group. Ann Intern Med. 1995;122:569–72.
Doudenko-Pirozzolo I, Booth R. A 20-year-old man with a history of hemoptysis and purpura. Arch Pathol Lab Med. 2001;125:835–7.
Leone G, Sica S, De Stefano V, et al. Acute onset of juvenile myelodysplastic syndrome mimicking thrombotic thrombocytopenic purpura and rapidly evolving in overt myeloid leukemia. Am J Hematol. 1992;41:64–5. doi:10.1002/ajh.2830410114.
Marisavljevic D, Kraguljac N, Rolovic Z. Immunologic abnormalities in myelodysplastic syndrome: clinical features and characteristics of the lymphoid population. Med Oncol. 2006;23:385–92. doi:10.1385/MO:23:3:385.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Sasaki, N., Kuroda, J., Kawata, E. et al. Thrombotic thrombocytopenic purpura associated with myelodysplastic syndrome. Int J Hematol 88, 457–459 (2008). https://doi.org/10.1007/s12185-008-0180-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12185-008-0180-6